Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The term Implant is used for the devices that replace or support biological structure. Implantable medical devices or tissues are placed inside or on the surface of the body for the replacement of missing biological structure or are used to provide support to the biological structure. Some Implantable devices are made up of metal, plastic ceramic or other materials and some are made from skin, bones or other body tissues. These devices can be placed permanently or temporally and they help in monitoring and treating clinical disorders.
According to the Australian Society of Orthopaedic Surgeons, the hospitalization rates for Australians with osteoarthritis increased in the 10 years to 2013-2014 to 415 hospitalizations per 100,000 populations from 362 hospitalizations per 100,000 populations in 2004?05. Over the same period the rate of knee replacement increased to 169 per 100,000 populations from 128. As per the data provided by Australian Orthopaedic Association National Joint Replacement Registry, there were 4,307 revision hip replacements and 4,101 revision knee replacements were reported in 2014.
Hence, with the rise in Orthopaedic surgeries, rise in the market of implantable medical devices could be expected. The key factors driving the growth of the market are growing incidences of cardiovascular diseases, technological advancements, growing acceptance of medical implants, improvement in healthcare infrastructure, and growth in the number of geriatric population. Based on Country, Asia-Pacific Implantable Medical Devices market is segmented into China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia-Pacific.
China remained the dominant Country in the Asia-Pacific Implantable Medical Devices market in 2015. India and South Korea would witness promising CAGR during the forecast period (2016-2022). The report covers the analysis of key stake holders of the Implantable Medical Devices market. Key companies profiled in the report include Abbott Laboratories., Boston Scientific Corporation, Conmed Corporation, Johnson & Johnson, Medtronic Plc, Smith And Nephew Plc, Stryker Corporation, C.R. Bard, Inc., Cardinal health, Inc. and Globus Medical, Inc.